News

AvePoint's Upcoming Financials: What to Expect for Q2 2025

AvePoint's Upcoming Financials: What to Expect for Q2 2025

AvePoint to Discuss Financial Results for Q2 2025

AvePoint (NASDAQ: AVPT), recognized as a leading force in data security, governance, and resilience, is set to announce its financial outcomes for the second quarter of 2025. This announcement is highly anticipated as it provides key insights into the company's operational success.

Details of the Financial Announcement

The announcement will take place after the financial markets close on a scheduled Thursday, where executives will present an overview of the financial results achieved during the quarter. This will be followed by an informative conference call where audience participation is encouraged.

Conference Call Availability

To ensure accessibility, the conference call is slated for 4:30 PM ET on the same Thursday. CEO Dr. Tianyi Jiang (TJ) and CFO Jim Caci will spearhead the session, sharing insights on the financial performance and outlining current trends affecting the business landscape. Interested parties can join the call through dedicated phone lines: US participants can dial 1 (833) 816-1428, while international participants should call 1 (412) 317-0520. A passcode of 0727391 will be necessary to access the call.

Outlook of AvePoint

AvePoint’s commitment to driving data confidence is reflected in the growing number of customers utilizing its services. The comprehensive AvePoint Confidence Platform caters to over 25,000 organizations globally, helping them secure their critical data across diverse environments including Microsoft, Google, and Salesforce. Such robust backing solidifies AvePoint’s role as a trusted provider in data management solutions.

Expanding Partnerships

The company’s extensive network of approximately 5,000 channel partners, consisting of managed service providers, value-added resellers, and systems integrators, ensures that its innovative solutions reach a wide array of markets. With its presence in over 100 cloud marketplaces, AvePoint continues to amplify its impact and delivers security measures that organizations worldwide rely on.

Why Attend the Call?

Attending the conference call provides an excellent opportunity for stakeholders to engage directly with the executives of AvePoint, to hear firsthand about the strategies being implemented, and to understand how the company is navigating challenges in the tech industry. Such insights can be crucial for investors and industry enthusiasts alike.

Customer Trust and Market Opportunities

Today, AvePoint is not just about data security; it’s about creating a resilient framework for businesses to thrive. The company's reputation as a thought leader comes from its proactive measures in securing data and maintaining compliance within regulatory frameworks. AvePoint remains dedicated to enhancing the confidence of its clients, fostering an environment where they can manage and optimize their data effectively.

Conclusion

The excitement surrounding AvePoint’s upcoming financial results stems not only from the numbers but from the story of a company on the cutting edge of technology and security. As they prepare to share their latest insights with the public, investors and customers can look forward to a discussion that might just shape the future of data governance.

Frequently Asked Questions

When will AvePoint announce its financial results?

The financial results will be announced after the markets close on a Thursday.

Who will be presenting during the conference call?

CEO Dr. Tianyi Jiang and CFO Jim Caci will present and host the session.

How can I join AvePoint's conference call?

Participants can join by calling the appropriate dial-in number and entering the passcode provided.

What is AvePoint’s primary service offering?

AvePoint is a leader in data security, governance, and resilience, providing solutions that help organizations manage their data safely.

How many customers does AvePoint serve worldwide?

AvePoint serves over 25,000 customers globally.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Synova Global Taps Eventus for Top Trade Surveillance

Updated Category News Views 144

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

Continue Reading
Cambiotics Launches Key Trial on Reducing PFAS in Firefighters

Updated Category News Views 44

Pioneering Efforts to Combat 'Forever Chemicals' Cambiotics is stepping into some uncharted territory—tackling the tricky problem of PFAS accumulation in firefighters. If you’ve been following this, PFAS, or per- and polyfluoroalkyl substances, have been living rent-free in our bodies for years. Used in firefighting equipment and foams, these chemicals stick around,...

Continue Reading
ZBS Group Takes Over Rabinowitz’s CPA Practice with Bold Moves

Updated Category News Views 44

Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....

Continue Reading
Connecting NIH Data: Transforming Scientific Discoveries

Updated Category News Views 44

Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...

Continue Reading
Cerbo's AI Scribe Expands to Telehealth Success

Updated Category News Views 46

Cerbo Enhances Telehealth With AI Scribe Expansion The digital healthcare playground looks like it's getting a nudge toward efficiency with Cerbo's latest move. Just when you thought telehealth couldn't get much sharper, these folks have drawn a line in the sand with their AI Scribe, which now makes its presence felt in virtual visits. No more juggling a dozen screens...

Continue Reading
SportsMed Expands to 58 Clinics, New Opening in Jersey City

Updated Category News Views 28

SportsMed Physical Therapy Expands with New Clinic Well, here we are, talking about expansion. And not just any expansion—I'm talking about SportsMed Physical Therapy flexing its muscles in Jersey City Heights, boosting their count to 58 clinics scattered across New Jersey and Connecticut. It's like watching a network of care roots spreading deeper into the region, and...

Continue Reading
Geopolitical Talks Shake Oil Market, Refine Stocks' Path

Updated Category News Views 92

Diplomacy Takes Center Stage So here we are again, riding the rollercoaster of geopolitics that's jerking the oil market around like a marionette. With the U.S. and Iran allegedly chatting—mind you, with a ton of smoke and mirrors through Qatar and Islamabad—every trader's watching, hoping for a ceasefire that might either stabilize or further jolt energy prices. Oil...

Continue Reading
Linker Vision's AI Platform Boosts Urban Planning

Updated Category News Views 72

Now, I've seen a fair share of tech rollouts claiming to change the world, but Linker Vision’s new AI platform, Linker AI Nexa, might actually be onto something real here. Revealed at the Smart City Expo World Congress 2026 in Barcelona, this isn't just another pretty interface—it’s packing some serious firepower with NVIDIA tech. Bringing Physical AI to City...

Continue Reading
Bright Minds Faces Legal Scrutiny Over FDA Trial Hold

Updated Category News Views 72

Bright Minds Biosciences Under the Microscope Well, it looks like Bright Minds Biosciences has found itself in some hot water with investors. After the FDA put a partial hold on their Phase 2 trial for BMB-101, designed for epilepsy treatment, the stock took a nosedive. If you're holding a piece of NASDAQ:DRUG, or even if you cut your losses and ran, it's time to tune in....

Continue Reading
Instanodes Tackling Quantum Threats in Blockchain

Updated Category News Views 114

Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...

Continue Reading

Top 5 Most Recently Viewed Articles

MindMaze Therapeutics: 2026 Business Update and Insights

Updated Category News Views 16

Breaking Down MindMaze’s 2026 Update Today, I’m sifting through MindMaze Therapeutics' latest half-year report like a prospector panning for gold nuggets. It’s a mixed bag, folks, full of expansion optimism underlined by a nagging loss in the financial ledger. But they say fortune favors the bold, right? The company has ambitious ideas, and their genetic makeup...

Continue Reading
Tantrum Sportfishing Celebrates Record Blue Marlin Achievement

Updated Category News Views 190

Historic Milestone for Tantrum Sportfishing In an inspiring turn of events for the sportfishing community, Tantrum Sportfishing has achieved a remarkable milestone. The Kona-based charter company announced its proud entry into the illustrious "Grander Club" after landing a colossal 1,039-pound Blue Marlin. This catch not only signifies a personal triumph for the team but...

Continue Reading
New Bitcoin ETF Offers Investors Unique Downside Protection

Updated Category News Views 227

Calamos Introduces a Groundbreaking Bitcoin ETF Investment management firm Calamos is excited to roll out an innovative approach to cryptocurrency investing with the launch of the world’s first 100% downside-protected Bitcoin exchange-traded fund (ETF). This launch comes just after an announcement suggesting that an ETF will be available for investors looking to...

Continue Reading
Exciting Developments in dsm-firmenich's Share Repurchase Initiative

Updated Category News Views 178

Progress Update on dsm-firmenich's Share Repurchase Program dsm-firmenich, known for its innovative approach in the fields of nutrition, health, and beauty, is actively implementing its large-scale share repurchase program. This initiative began earlier this year and signifies a strategic move to enhance shareholder value and manage capital effectively. Initial...

Continue Reading
Capricor Therapeutics: Key Deadlines for Shareholders to Remember

Updated Category News Views 133

Crucial Dates for Capricor Therapeutics Shareholders The Gross Law Firm has released an important notice for shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). The firm encourages anyone who purchased shares during the specified class period to connect with them regarding possible lead plaintiff appointments. Being appointed as the lead plaintiff isn't necessary...

Continue Reading